Objectives: To explore the relationship between aural symptoms during baro-challenge and the underlying measured Eustachian tube (ET) function. Two key questions were addressed. (1) In patients who have features of obstructive ET dysfunction, is there a measurable underlying difference in ET function between those who experience severe symptoms on baro-challenge and those that do not? (2) What is the diagnostic value of ET function tests in the identification of patients with severe symptoms on baro-challenge? Methods: Patients with symptoms of obstructive ET dysfunction were recruited, with the presence of aural symptoms on baro-challenge established via the clinical history and analysis of the Cambridge ET Dysfunction Assessment, a patient-reported outcome measure (PROM). ET function tests were assessed in each patient: 9 objective and semi-objective measures of ET opening, and 2 symptom-based PROMs. The tests’ results were grouped by type of ET opening assessed, generating passive and active dysfunction scores. Individual test results were assessed for diagnostic accuracy in reference to features in the history or PROM-based evidence of symptoms on baro-challenge. Results: Both passive and active opening of the ET was significantly reduced in ears with a history of pain on baro-challenge. Some patients had apparent severe obstructive ET dysfunction without symptoms on baro-challenge, whilst others had symptoms but normal test results. No individual test of ET opening was of diagnostic value in predicting those ears likely to experience pain or exacerbated symptoms on baro-challenge. Conclusion: The relationship between aural pain during baro-challenge and ET function appears more complex than had been assumed, with pain possibly related to factors other than just ET function.

1.
Arnold
W
,
Hausler
R
.
Otosclerosis and Stapes Surgery
.
Basel, Switzerland
:
S Karger AG
;
2007
.
2.
Doyle
WJ
,
Singla
A
,
Banks
J
,
El-Wagaa
J
,
Swarts
JD
.
Pressure chamber tests of eustachian tube function document lower efficiency in adults with colds when compared to without colds
.
Acta Otolaryngol
.
2014
Jul
;
134
(
7
):
691
7
.
[PubMed]
0001-6489
3.
Gaihede
M
,
Dirckx
JJ
,
Jacobsen
H
,
Aernouts
J
,
Søvsø
M
,
Tveterås
K
.
Middle ear pressure regulation—complementary active actions of the mastoid and the Eustachian tube
.
Otol Neurotol
.
2010
Jun
;
31
(
4
):
603
11
.
[PubMed]
1531-7129
4.
Jenckel
F
,
Kappo
N
,
Gliese
A
,
Loewenthal
M
,
Lörincz
BB
,
Knecht
R
, et al.
Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Estève) in outcomes measurement
.
Eur Arch Otorhinolaryngol
.
2015
Dec
;
272
(
12
):
3677
83
.
[PubMed]
0937-4477
5.
Lima
MA
,
Farage
L
,
Cury
MC
,
Bahamad
F
.
Update on middle ear barotrauma after hyperbaric oxygen therapy-insights on pathophysiology
.
Int Arch Otorhinolaryngol
.
2014
Apr
;
18
(
2
):
204
9
.
[PubMed]
1809-9777
6.
Liu
P
,
Su
K
,
Zhu
B
,
Wu
Y
,
Shi
H
,
Yin
S
.
Detection of eustachian tube openings by tubomanometry in adult otitis media with effusion
.
Eur Arch Otorhinolaryngol
.
2016
Oct
;
273
(
10
):
3109
15
.
[PubMed]
0937-4477
7.
McCoul
ED
,
Anand
VK
,
Christos
PJ
.
Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire (ETDQ-7)
.
Laryngoscope
.
2012
May
;
122
(
5
):
1137
41
.
[PubMed]
0023-852X
8.
Meyer
MF
,
Korthauer
C
,
Jansen
S
,
Huttenbrink
KB
,
Beutner
D
:
Analyzing eustachian tube function in patients with symptoms of chronical Eustachian tube dysfunction by pressure chamber measurements.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies
2018
;275:1087-1094.
9.
Sadé
J
,
Ar
A
,
Fuchs
C
.
Barotrauma vis-a-vis the “chronic otitis media syndrome”: two conditions with middle ear gas deficiency Is secretory otitis media a contraindication to air travel?
Ann Otol Rhinol Laryngol
.
2003
Mar
;
112
(
3
):
230
5
.
[PubMed]
0003-4894
10.
Schilder
AG
,
Bhutta
MF
,
Butler
CC
,
Holy
C
,
Levine
LH
,
Kvaerner
KJ
, et al.
Eustachian tube dysfunction: consensus statement on definition, types, clinical presentation and diagnosis
.
Clin Otolaryngol
.
2015
Oct
;
40
(
5
):
407
11
.
[PubMed]
1749-4478
11.
Schwarz
D
,
Jansen
S
,
Steinhauser
S
,
Meyer
MF
.
Evaluation of the Parameter “Mean Impedance” for Representing Eustachian tube Functions During Pressure Increase and Decrease in Pressure Chamber Measurements. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society
.
[and]
.
European Academy of Otology and Neurotology
.
2019
;
40
(
5
):
e527
31
.
12.
Singh
T
,
Taneja
V
,
Kulendra
K
,
Farr
M
,
Robinson
J
,
Rejali
D
.
Balloon Eustachian tuboplasty treatment of longstanding Eustachian tube dysfunction
.
J Laryngol Otol
.
2017
Jul
;
131
(
7
):
614
9
.
[PubMed]
0022-2151
13.
Smith
ME
,
Blythe
AJ
,
Baker
C
,
Zou
CC
,
Hutchinson
PJ
,
Tysome
JR
.
Tests of Eustachian Tube Function: the Effect of Testing Technique on Tube Opening in Healthy Ears
.
Otol Neurotol
.
2017
a
Jun
;
38
(
5
):
714
20
.
[PubMed]
1531-7129
14.
Smith
ME
,
Cochrane
IL
,
Donnelly
N
,
Axon
PR
,
Tysome
JR
.
The Performance of Patient-reported Outcome Measures as Diagnostic Tools for Eustachian Tube Dysfunction
.
Otol Neurotol
.
2018
a
Oct
;
39
(
9
):
1129
38
.
[PubMed]
1531-7129
15.
Smith
ME
,
Takwoingi
Y
,
Deeks
J
,
Alper
C
,
Bance
ML
,
Bhutta
MF
, et al.
Eustachian tube dysfunction: A diagnostic accuracy study and proposed diagnostic pathway
.
PLoS One
.
2018
b
Nov
;
13
(
11
):
e0206946
.
[PubMed]
1932-6203
16.
Smith
ME
,
Zou
CC
,
Baker
C
,
Blythe
AJ
,
Hutchinson
PJ
,
Tysome
JR
.
The repeatability of tests of eustachian tube function in healthy ears
.
Laryngoscope
.
2017
b
Nov
;
127
(
11
):
2619
26
.
[PubMed]
0023-852X
17.
Tailor
BV
,
Smith
ME
,
Hutchinson
PJ
,
Tysome
JR
.
Outcome Measures for Baro-Challenge-Induced Eustachian Tube Dysfunction: A Systematic Review
.
Otol Neurotol
.
2018
Feb
;
39
(
2
):
138
49
.
[PubMed]
1531-7129
18.
Teixeira
MS
,
Swarts
JD
,
Alper
CM
.
Accuracy of the ETDQ-7 for Identifying Persons with Eustachian Tube Dysfunction
.
Otolaryngol Head Neck Surg
.
2018
Jan
;
158
(
1
):
83
9
.
[PubMed]
0194-5998
19.
Toklu
AS
,
Shupak
A
,
Yildiz
S
,
Aktas
S
,
Ertracht
O
,
Ay
H
, et al.
Aural barotrauma in submarine escape: is mastoid pneumatization of significance?
Laryngoscope
.
2005
Jul
;
115
(
7
):
1305
9
.
[PubMed]
0023-852X
20.
Tos
M
,
Stangerup
SE
,
Hvid
G
.
Mastoid pneumatization. Evidence of the environmental theory
.
Arch Otolaryngol
.
1984
Aug
;
110
(
8
):
502
7
.
[PubMed]
0003-9977
21.
Uzun
C
,
Adali
MK
,
Koten
M
,
Yagiz
R
,
Aydin
S
,
Cakir
B
, et al.
Relationship between mastoid pneumatization and middle ear barotrauma in divers
.
Laryngoscope
.
2002
Feb
;
112
(
2
):
287
91
.
[PubMed]
0023-852X
22.
Uzun
C
.
Evaluation of predive parameters related to eustachian tube dysfunction for symptomatic middle ear barotrauma in divers
.
Otol Neurotol
.
2005
Jan
;
26
(
1
):
59
64
.
[PubMed]
1531-7129
23.
Whiting
P
,
Rutjes
AW
,
Reitsma
JB
,
Glas
AS
,
Bossuyt
PM
,
Kleijnen
J
.
Sources of variation and bias in studies of diagnostic accuracy: a systematic review
.
Ann Intern Med
.
2004
Feb
;
140
(
3
):
189
202
.
[PubMed]
0003-4819
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.